Abivax (EPA: ABVX) stock: the official figures
Abivax (ABIVAX) is listed on Euronext Paris under the ticker ABVX and belongs to the health care sector. In fiscal 2025 it reported a net loss of €336.1m, according to the annual accounts it filed with the regulator.
Identifiers for Abivax: ISIN FR0012333284 · LEI 969500D8TMNB184OJU95.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Operating profit | −€246.1m | −€173.0m | — |
| Net profit | −€336.1m | −€176.2m | — |
| Earnings per share | −€4.83 | −€2.80 | — |
| Total assets | €584.3m | €205.2m | +184.7% |
| Equity | €455.2m | €40.6m | +1,021.6% |
| Cash | €516.7m | €144.2m | +258.3% |
| Operating cash flow | −€161.1m | −€154.1m | — |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
5 fiscal years
| Fiscal year | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|
| 2025 | −€246.1m | −€336.1m | −€4.83 | Annual report |
| 2024 | −€173.0m | −€176.2m | −€2.80 | Annual report |
| 2023 | −€127.4m | −€147.7m | −€3.43 | Annual report |
| 2022 | −€64.8m | −€60.7m | −€3.18 | — |
| 2021 | −€41.4m | −€42.5m | −€2.75 | — |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Abivax. Year by year: net income.
Frequently asked questions about Abivax
- How much did Abivax earn in fiscal 2025?
- Abivax reported a net loss of €336.1m for fiscal 2025. The year before it reported a net loss of €176.2m.
- What are the earnings per share of Abivax?
- They were −€4.83 in fiscal 2025, compared with −€2.80 the year before.
- Where is Abivax listed?
- Abivax is listed on Euronext Paris under the ticker ABVX and belongs to the health care sector.
- What is the ISIN of Abivax?
- The ISIN of Abivax is FR0012333284, the international code that identifies its shares. Its LEI, the legal entity identifier, is 969500D8TMNB184OJU95.
- Where do the figures for Abivax come from?
- From the report Abivax files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the report Abivax files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.